Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VANI
VANI | US
1.35
USD0.04
3.05%
VANI | US
Loading StockChartView...
About VANI
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.35
Open
1.31
High
1.38
Low
1.29
Vivani Medical Inc. a clinical stage company develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville California.
View LessVANI | US
Risk
95.9
Sharpe
0.37
Luna's Score
39/100
Recommendation
Sell
Luna says (VANI | US)
What's Working
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
107.7%1 month
95.9%3 months
75.7%6 months
68.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.02
Debt to equity
0.84
Debt to assets
0.42
Ent. to EBITDA
-3.93
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-24.90M
MarketCap
74.60M
MarketCap(USD)
74.60M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-86.10
Short ratio
8.90
Short perc.
2.98
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.52
Range1M
0.61
Range3M
0.62
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.62
Price X volume
259.49K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.93 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.02 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 75.67 | 72.80 | Par |
| Debt to Equity | 0.84 | -1.23 | Expensive |
| Debt to Assets | 0.42 | 0.25 | Expensive |
| Market Cap | 74.60M | 3.66B | Emerging |
